Genetic and Racial Differences in the Vitamin D Endocrine System

Endocrinology and Metabolism Clinics of North America

Volumn 46, Issue 4, 2017, Pages 1119-1135

  Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

25 Hydroxyvitamin D; CYP24A1; CYP2R1; Delta 7 steroid reductase; Gene polymorphism; Race; Vitamin D; Vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; COLECALCIFEROL 24 HYDROXYLASE; VITAMIN D; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D;

CYP24A1 GENE; CYP2R1 GENE; DELTA 7 STEROID REDUCTASE GENE; ENDOCRINE SYSTEM; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENE; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENOME-WIDE ASSOCIATION STUDY; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RACE DIFFERENCE; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; BLOOD; GENETIC VARIATION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D DEFICIENCY;

GENETIC VARIATION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85030485154     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2017.07.014     Document Type: Review

References (111)

1. Bouillon, R., Carmeliet, G., Verlinden, L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:6 (2008), 726–776.
2. Bouillon, R., Vitamin D: from photosynthesis, metabolism, and action to clinical applications. Jameson, J.L., De Groot, L.J., (eds.) Endocrinology: adult and pediatric, 2016, Saunders/Elsevier, Philadelphia, 1018–1038.
3. Rosen, C.J., Adams, J.S., Bikle, D.D., et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33:3 (2012), 456–492.
4. Bikle, D.D., Extraskeletal actions of vitamin D. Ann N Y Acad Sci 1376:1 (2016), 29–52.
5. Cashman, K.D., Seamans, K.M., Lucey, A.J., et al. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am J Clin Nutr 95:6 (2012), 1350–1356.
6. Jetter, A., Egli, A., Dawson-Hughes, B., et al. Pharmacokinetics of oral vitamin D(3) and calcifediol. Bone 59 (2014), 14–19.
7. Spiro, A., Buttriss, J.L., Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull 39:4 (2014), 322–350.
8. Bouillon, R., Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol 13:8 (2017), 466–479.
9. Holick, M.F., Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health. Anticancer Res 36:3 (2016), 1345–1356.
10. Holick, M.F., Vitamin D deficiency. N Engl J Med 357:3 (2007), 266–281.
11. Petersen, B., Wulf, H.C., Triguero-Mas, M., et al. Sun and ski holidays improve vitamin D status, but are associated with high levels of DNA damage. J Invest Dermatol 134:11 (2014), 2806–2813.
12. Luxwolda, M.F., Kuipers, R.S., Kema, I.P., et al. Vitamin D status indicators in indigenous populations in East Africa. Eur J Nutr 52:3 (2013), 1115–1125.
13. Laurent, M.R., Gielen, E., Pauwels, S., et al. Hypervitaminosis D associated with tanning bed use: a case report. Ann Intern Med 166:2 (2017), 155–156.
14. Durazo-Arvizu, R.A., Camacho, P., Bovet, P., et al. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr 100:3 (2014), 908–914.
15. Bassil, D., Rahme, M., Hoteit, M., et al. Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5:2 (2013), 274–298.
16. Al-Daghri, N.M., Al-Attas, O.S., Alokail, M.S., et al. Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) 76:3 (2012), 346–350.
17. Prabhu, A.V., Luu, W., Sharpe, L.J., et al. Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis. J Biol Chem 291:16 (2016), 8363–8373.
18. Zou, L., Porter, T.D., Rapid suppression of 7-dehydrocholesterol reductase activity in keratinocytes by vitamin D. J Steroid Biochem Mol Biol 148 (2015), 64–71.
19. Anstey, A., Photomedicine: lessons from the Smith-Lemli-Opitz syndrome. J Photochem Photobiol B 62:3 (2001), 123–127.
20. Rossi, M., Federico, G., Corso, G., et al. Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 28:1 (2005), 69–80.
21. Hazewinkel, H.A., Tryfonidou, M.A., Vitamin D3 metabolism in dogs. Mol Cell Endocrinol 197:1–2 (2002), 23–33.
22. Morris, J.G., Ineffective vitamin D synthesis in cats is reversed by an inhibitor of 7-dehydrocholestrol-delta7-reductase. J Nutr 129:4 (1999), 903–908.
23. Vantieghem, K., De Haes, P., Bouillon, R., et al. Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation. J Photochem Photobiol B 85:1 (2006), 72–78.
24. Vantieghem, K., Overbergh, L., Carmeliet, G., et al. UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor. J Cell Biochem 99:1 (2006), 229–240.
25. Wang, T.J., Zhang, F., Richards, J.B., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:9736 (2010), 180–188.
26. Ahn, J., Yu, K., Stolzenberg-Solomon, R., et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19:13 (2010), 2739–2745.
27. Hiraki, L.T., Major, J.M., Chen, C., et al. Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 37:1 (2013), 92–98.
28. Zhang, Y., Wang, X., Liu, Y., et al. The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly, 142, 2012, w13636.
29. Lu, L., Sheng, H., Li, H., et al. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum Genet 131:3 (2012), 505–512.
30. Reboul, E., Goncalves, A., Comera, C., et al. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res 55:5 (2011), 691–702.
31. Borel, P., Moussa, M., Reboul, E., et al. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr 137:12 (2007), 2653–2659.
32. Dueland, S., Pedersen, J.I., Helgerud, P., et al. Absorption, distribution, and transport of vitamin D3 and 25-hydroxyvitamin D3 in the rat. Am J Physiol 245:5 Pt 1 (1983), E463–E467.
33. Dueland, S., Bouillon, R., Van Baelen, H., et al. Binding protein for vitamin D and its metabolites in rat mesenteric lymph. Am J Physiol 249:1 Pt 1 (1985), E1–E5.
34. Bouillon R, Pauwels S. Vitamin D binding protein. In: Feldman D, Pike JW, Adams J, editors. Vitamin D. London: Elsevier, in press.
35. Bouillon, R., Vanassche, F.A., Vanbaelen, H., et al. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3-significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67:3 (1981), 589–596.
36. Chun, R.F., Peercy, B.E., Orwoll, E.S., et al. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144 Pt A (2014), 132–137.
37. Bikle, D., Bouillon, R., Thadhani, R., et al. Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status?. J Steroid Biochem Mol Biol, 2017 [Epub ahead of print].
38. Cleve, H., Constans, J., The mutants of the vitamin D-binding protein - more than 120 variants of the GC/DBP system. Vox Sang 54:4 (1988), 215–225.
39. Verboven, C., Ragijns, A., De Maeyer, M., et al. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 9:2 (2002), 131–136.
40. Kamboh, M.I., Ferrell, R.E., Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet 72:4 (1986), 281–293.
41. Powe, C.E., Evans, M.K., Wenger, J., et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369:21 (2013), 1991–2000.
42. Aloia, J., Mikhail, M., Dhaliwal, R., et al. Free 25(OH)D and the vitamin D paradox in African Americans. J Clin Endocrinol Metab 100:9 (2015), 3356–3363.
43. Bouillon, R., Jones, K., Schoenmakers, I., Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med, 370(9), 2014, 879.
44. Denburg, M.R., Hoofnagle, A.N., Sayed, S., et al. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res 31:6 (2016), 1128–1136.
45. Nielson, C.M., Jones, K.S., Chun, R.F., et al. Role of assay type in determining free 25-hydroxyvitamin D levels in diverse populations. N Engl J Med 374:17 (2016), 1695–1696.
46. Nielson, C.M., Jones, K.S., Chun, R.F., et al. Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations. J Clin Endocrinol Metab 101:5 (2016), 2226–2234.
47. Carpenter, T.O., Zhang, J.H., Parra, E., et al. Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone Miner Res 28:1 (2013), 213–221.
48. Lauridsen, A.L., Vestergaard, P., Nexo, E., Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47:4 (2001), 753–756.
49. Sapkota, B.R., Hopkins, R., Bjonnes, A., et al. Genome-wide association study of 25(OH) Vitamin D concentrations in Punjabi Sikhs: results of the Asian Indian diabetic heart study. J Steroid Biochem Mol Biol 158 (2016), 149–156.
50. Dastani, Z., Li, R., Richards, B., Genetic regulation of vitamin D levels. Calcif Tissue Int 92:2 (2013), 106–117.
51. Bouillon, R., Genetic and environmental determinants of vitamin D status. Lancet 376:9736 (2010), 148–149.
52. Zhang, Z., He, J.W., Fu, W.Z., et al. An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. J Bone Miner Res 28:8 (2013), 1784–1792.
53. Bouillon, R., Vandoren, G., Van Baelen, H., et al. Lack of effect of the vitamin D status on the concentration of the vitamin D-binding protein in rat serum. Endocrinology 107:1 (1980), 160–163.
54. Arnaud, J., Constans, J., Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92:2 (1993), 183–188.
55. Kawakami, M., Imawari, M., Goodman, D.S., Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem J 179:2 (1979), 413–423.
56. Bouillon, R., van Baelen, H., de Moor, P., Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem 13:9 (1980), 1029–1034.
57. Boutin, B., Galbraith, R.M., Arnaud, P., Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J Steroid Biochem 32:1A (1989), 59–63.
58. Srikanth, P., Chun, R.F., Hewison, M., et al. Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men. Osteoporos Int 27:7 (2016), 2291–2300.
59. Janssens, W., Bouillon, R., Claes, B., et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65:3 (2010), 215–220.
60. Delanghe, J.R., Speeckaert, R., Speeckaert, M.M., Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 29:5 (2015), 773–786.
61. Cheng, J.B., Levine, M.A., Bell, N.H., et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101:20 (2004), 7711–7715.
62. Levine, M.A., Dang, A., ding, C., et al. Tropical rickets in Nigeria: mutation of the CYP2R1 gene encoding vitamin D 25-hydroxylase as a cause of vitamin D dependent rickets. Bone 40:6 suppl 1 (2007), S60–S61.
63. Thacher, T.D., Fischer, P.R., Singh, R.J., et al. CYP2R1 mutations impair generation of 25-hydroxyvitamin D and cause an atypical form of vitamin D deficiency. J Clin Endocrinol Metab 100:7 (2015), E1005–E1013.
64. Al Mutair, A.N., Nasrat, G.H., Russell, D.W., Mutation of the CYP2R1 vitamin D 25-hydroxylase in a Saudi Arabian family with severe vitamin D deficiency. J Clin Endocrinol Metab 97:10 (2012), E2022–E2025.
65. Nissen, J., Rasmussen, L.B., Ravn-Haren, G., et al. Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults. PLoS One, 9(2), 2014, e89907.
66. Signorello, L.B., Shi, J., Cai, Q., et al. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS One, 6(12), 2011, e28623.
67. Elkum, N., Alkayal, F., Noronha, F., et al. Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS One, 9(11), 2014, e113102.
68. Fohner, A.E., Wang, Z., Yracheta, J., et al. Genetics, diet, and season are associated with serum 25-hydroxycholecalciferol concentration in a Yup'ik study population from southwestern Alaska. J Nutr 146:2 (2016), 318–325.
69. Xu, X., Mao, J., Zhang, M., et al. Vitamin D deficiency in Uygurs and Kazaks is associated with polymorphisms in CYP2R1 and DHCR7/NADSYN1 genes. Medical science monitor. Int Med J Exp Clin Res 21 (2015), 1960–1968.
70. Orton, S.M., Morris, A.P., Herrera, B.M., et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88:2 (2008), 441–447.
71. Schlingmann, K.P., Kaufmann, M., Weber, S., et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:5 (2011), 410–421.
72. Cools, M., Goemaere, S., Baetens, D., et al. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: a cross-sectional study. Bone 81 (2015), 89–96.
73. Jones, K.S., Assar, S., Harnpanich, D., et al. 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab 99:9 (2014), 3373–3381.
74. Bouillon, R., Van Schoor, N.M., Gielen, E., et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98:8 (2013), E1283–E1304.
75. Ordonez-Mena, J.M., Maalmi, H., Schottker, B., et al. Genetic variants in the vitamin D pathway, 25(OH)D levels, and mortality in a large population-based cohort study. J Clin Endocrinol Metab 102:2 (2017), 470–477.
76. Hunter, D., De Lange, M., Snieder, H., et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16:2 (2001), 371–378.
77. Wjst, M., Altmuller, J., Braig, C., et al. A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol 103:3–5 (2007), 799–802.
78. Orton, S.M., Ebers, G.C., Heritability of serum vitamin D concentrations: twin studies. Am J Clin Nutr 93:3 (2011), 667–668 [author reply: 668].
79. Engelman, C.D., Fingerlin, T.E., Langefeld, C.D., et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93:9 (2008), 3381–3388.
80. Snellman, G., Melhus, H., Gedeborg, R., et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One, 4(11), 2009, e7747.
81. Shea, M.K., Benjamin, E.J., Dupuis, J., et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 63:4 (2009), 458–464.
82. Karohl, C., Su, S., Kumari, M., et al. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 92:6 (2010), 1393–1398.
83. Mills, N.T., Wright, M.J., Henders, A.K., et al. Heritability of transforming growth factor-beta1 and tumor necrosis factor-receptor type 1 expression and vitamin D levels in healthy adolescent twins. Twin Res Hum Genet 18:1 (2015), 28–35.
84. Arguelles, L.M., Langman, C.B., Ariza, A.J., et al. Heritability and environmental factors affecting vitamin D status in rural Chinese adolescent twins. J Clin Endocrinol Metab 94:9 (2009), 3273–3281.
85. Haddock, L., Corcino, J., Vazquez, M.D., 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and paratyroid disease. P R Health Sci J 1 (1982), 85–91.
86. Haddad, J.G., Chyu, K.J., Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:6 (1971), 992–995.
87. Better, O.S., Shabtai, M., Kedar, S., et al. Increased incidence of nephrolithiasis (N) in lifeguards (LG) in Israel. Adv Exp Med Biol 128 (1980), 467–472.
88. Barger-Lux, M.J., Heaney, R.P., Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:11 (2002), 4952–4956.
89. M'Buyamba-Kabangu, J.R., Fagard, R., Lijnen, P., et al. Calcium, vitamin D-endocrine system, and parathyroid hormone in black and white males. Calcif Tissue Int 41:2 (1987), 70–74.
90. Luxwolda, M.F., Kuipers, R.S., Kema, I.P., et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 108:9 (2012), 1557–1561.
91. Pettifor, J.M., Prentice, A., The role of vitamin D in paediatric bone health. Best Pract Res Clin Endocrinol Metab 25:4 (2011), 573–584.
92. Thacher, T.D., Fischer, P.R., Pettifor, J.M., et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 341:8 (1999), 563–568.
93. Prentice, A., Ceesay, M., Nigdikar, S., et al. FGF23 is elevated in Gambian children with rickets. Bone 42:4 (2008), 788–797.
94. Prentice, A., Vitamin D deficiency: a global perspective. Nutr Rev 66:10 Suppl 2 (2008), S153–S164.
95. Vanlint, S.J., Morris, H.A., Newbury, J.W., et al. Vitamin D insufficiency in Aboriginal Australians. Med J Aust 194:3 (2011), 131–134.
96. Hilger, J., Friedel, A., Herr, R., et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr 111:1 (2014), 23–45.
97. Schleicher, R.L., Sternberg, M.R., Lacher, D.A., et al. The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am J Clin Nutr 104:2 (2016), 454–461.
98. Cashman, K.D., Dowling, K.G., Skrabakova, Z., et al. Vitamin D deficiency in Europe: pandemic?. Am J Clin Nutr 103:4 (2016), 1033–1044.
99. Arabi, A., El Rassi, R., El-Hajj Fuleihan, G., Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6:10 (2010), 550–561.
100. Zhang, W., Stoecklin, E., Eggersdorfer, M., A glimpse of vitamin D status in Mainland China. Nutrition 29:7–8 (2013), 953–957.
101. Powe, C.E., Ricciardi, C., Berg, A.H., et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26:7 (2011), 1609–1616.
102. Bhan, I., Powe, C.E., Berg, A.H., et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int 82:1 (2012), 84–89.
103. Denburg, M.R., Kalkwarf, H.J., de Boer, I.H., et al. Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol 28:9 (2013), 1843–1853.
104. Schwartz, J.B., Lai, J., Lizaola, B., et al. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab 99:5 (2014), 1631–1637.
105. Winters, S.J., Chennubhatla, R., Wang, C., et al. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 58:4 (2009), 438–442.
106. Lauridsen, A.L., Vestergaard, P., Hermann, A.P., et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77:1 (2005), 15–22.
107. Fang, Y., van Meurs, J.B.J., Arp, P., et al. Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 85:2 (2009), 85–93.
108. Sinotte, M., Diorio, C., Berube, S., et al. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89:2 (2009), 634–640.
109. Bu, F.X., Armas, L., Lappe, J., et al. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet 128:5 (2010), 549–556.
110. Pekkinen, M., Saarnio, E., Viljakainen, H.T., et al. Vitamin D binding protein genotype is associated with serum 25-hydroxyvitamin D and PTH concentrations, as well as bone health in children and adolescents in Finland. PLoS One, 9(1), 2014, e87292.
111. Lafi, Z.M., Irshaid, Y.M., El-Khateeb, M., et al. Association of rs7041 and rs4588 polymorphisms of the vitamin D binding protein and the rs10741657 polymorphism of CYP2R1 with vitamin D Status among Jordanian patients. Genet Test Mol Biomarkers 19:11 (2015), 629–636.